Kiessling, David
Rennings, Corinna
Hild, Matthias
Lappas, Alexandra
Dietlein, Thomas Stefan
Roessler, Gernot Franz
Widder, Randolf Alexander http://orcid.org/0000-0001-7487-1501
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Received: 11 July 2023
Revised: 15 September 2023
Accepted: 12 October 2023
First Online: 11 November 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review board as well as the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The Institutional Review Board (Ethik und Kommission Klinische Studien, Dernbacher Gruppe Katharina Kasper, Germany) approved the study.
: For this type of study (anonymized data, retrospective analysis), formal consent is not required.
: David Kiessling: none, Corinna Rennings: none, Matthias Hild: none, Alexandra Lappas: none, Gernot F. Roessler: none, Randolf A. Widder: none; and Thomas S. Dietlein: Santen Pharmaceutical Osaka Japan, Alcon Fort Worth USA. Stock interest: Bayer Leverkusen Germany, Johnson & Johnson New Brunswick, New Jersey. Lectures: Thea Pharma Schaffhausen Switzerland, iStar Medical Wawre Belgium, MeyeTech Alsdorf Germany.